Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Hypertrophy

Citations 291-300 of 489 total displayed.

Past content (since Jan 1999):

Clinical Investigations
Increased Angiotensin-(1-7)–Forming Activity in Failing Human Heart Ventricles: Evidence for Upregulation of the Angiotensin-Converting Enzyme Homologue ACE2
Lawrence S. Zisman, Rebecca S. Keller, Barbara Weaver, Qishan Lin, Robert Speth, Michael R. Bristow, and Charles C. Canver
Circulation 2003;108:1707-1712; published online before print as doi:10.1161/01.CIR.0000094734.67990.99 [Abstract] [Full text]  

Articles
Cardiac Angiotensin-(1-7) in Ischemic Cardiomyopathy
David B. Averill, Yuichiro Ishiyama, Mark C. Chappell, and Carlos M. Ferrario
Circulation published September 29, 2003, doi:10.1161/01.CIR.0000092888.63239.54 [Abstract]  

Articles
Effects of Eplerenone, Enalapril, and Eplerenone/Enalapril in Patients With Essential Hypertension and Left Ventricular Hypertrophy. The 4E-Left Ventricular Hypertrophy Study
Bertram Pitt, Nathaniel Reichek, Roland Willenbrock, Faiez Zannad, Robert A. Phillips, Barbara Roniker, Jay Kleiman, Scott Krause, Daniel Burns, and Gordon H. Williams
Circulation published September 29, 2003, doi:10.1161/01.CIR.0000091405.00772.6E [Abstract]  

Articles
Increased Angiotensin-(1-7)-Forming Activity in Failing Human Heart Ventricles. Evidence for Upregulation of the Angiotensin-Converting Enzyme Homologue ACE2
Lawrence S. Zisman, Rebecca S. Keller, Barbara Weaver, Qishan Lin, Robert Speth, Michael R. Bristow, and Charles C. Canver
Circulation published September 22, 2003, doi:10.1161/01.CIR.0000094734.67990.99 [Abstract]  

Articles
Angiotensin-(1-7) Formation in the Intact Human Heart. In Vivo Dependence on Angiotensin II as Substrate
Lawrence S. Zisman, Glenn E. Meixell, Michael R. Bristow, and Charles C. Canver
Circulation published September 22, 2003, doi:10.1161/01.CIR.0000094733.61689.D4 [Abstract]  

Basic Science Reports
Consequences of Pressure Overload on Sarcomere Protein Mutation-Induced Hypertrophic Cardiomyopathy
Joachim P. Schmitt, Christopher Semsarian, Michael Arad, Joseph Gannon, Ferhaan Ahmad, Catherine Duffy, Richard T. Lee, Christine E. Seidman, and J.G. Seidman
Circulation 2003;108:1133-1138; published online before print as doi:10.1161/01.CIR.0000086469.85750.48 [Abstract] [Full text]  

Basic Science Reports
Targeted Overexpression of Transmembrane Tumor Necrosis Factor Provokes a Concentric Cardiac Hypertrophic Phenotype
Ziad I. Dibbs, Abhinav Diwan, Shintaro Nemoto, Gilberto DeFreitas, Maha Abdellatif, Blase A. Carabello, Francis G. Spinale, Giora Feuerstein, Natarajan Sivasubramanian, and Douglas L. Mann
Circulation 2003;108:1002-1008; published online before print as doi:10.1161/01.CIR.0000085203.46621.F4 [Abstract] [Full text]  

Articles
Consequences of Pressure Overload on Sarcomere Protein Mutation-Induced Hypertrophic Cardiomyopathy
Joachim P. Schmitt, Christopher Semsarian, Michael Arad, Joseph Gannon, Ferhaan Ahmad, Catherine Duffy, Richard T. Lee, Christine E. Seidman, and J. G. Seidman
Circulation published August 18, 2003, doi:10.1161/01.CIR.0000086469.85750.48 [Abstract]  

Editorials
Is Nuclear Factor {kappa}B an Attractive Therapeutic Target for Treating Cardiac Hypertrophy?
Nicole H. Purcell and Jeffery D. Molkentin
Circulation 2003;108:638-640, doi:10.1161/01.CIR.0000085362.40608.DD [Full text]  

Editorials
Leptin: A Novel Link Between Obesity, Diabetes, Cardiovascular Risk, and Ventricular Hypertrophy
Sawsan Sader, Min Nian, and Peter Liu
Circulation 2003;108:644-646, doi:10.1161/01.CIR.0000081427.01306.7D [Full text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49

* Subspecialty Collections Home

* Show  Hypertrophy
 collections from other journals.

* Related collections:
 Etiology
 Acute coronary syndromes
 Acute myocardial infarction
 Arrhythmias, clinical electrophysiology, drugs
 Cardiac development
 Chronic ischemic heart disease
 Clinical genetics
 Epidemiology
 Heart failure
 Hypertension
 Hypertrophy
 Infectious endocarditis
 Lipids
 Myocardial cardiomyopathy disease
 Obesity
 Pericardial disease
 Peripheral vascular disease
 Pulmonary circulation and disease
 Remodeling
 Restenosis
 Valvular heart disease
 Other etiology